Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
304
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SillaJen Inc
•
03 Nov 2016 11:26
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
Sanghyun Park
Follow
257 Views
Share
bullish
•
Samsung Biologics
•
01 Nov 2016 18:11
Samsung BioLogics IPO - Why Investors Are Excited & Concerned
Samsung BioLogics will have a big day tomorrow. Nov 2-3 will be the subscription day. The company has already had a huge success with the...
Sanghyun Park
Follow
296 Views
Share
bullish
•
Samsung Biologics
•
28 Oct 2016 06:59
Samsung BioLogics IPO Price Is Set At Highest End (₩136,000) - 3 Points to Consider
Maeil Economic Daily, Korea's largest financial newspaper, has just reported that Samsung BioLogics' IPO price was set at ₩136,000, which is the...
Sanghyun Park
Follow
247 Views
Share
bullish
•
Samsung Biologics
•
27 Oct 2016 13:11
Samsung BioLogics' Revised Valuation Based on P/B Multiple
In another regulatory filing, Samsung BioLogics presented a revised valuation based on P/B multiple. Obviously, there are still many people who are...
Sanghyun Park
Follow
237 Views
Share
bearish
•
Samsung Biologics
•
27 Oct 2016 04:46
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
Kemp Dolliver, CFA
229 Views
Share
First
Previous
54
55
56
57
58
59
60
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x